Navigation Links
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Date:8/21/2008

yer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com.

Forward Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer Web site at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the results of the clinical development, safety, regulatory processes, commercialization efforts or commercial potential of Nexav
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCarePharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
2. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
6. Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
7. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
8. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014   GS1 US ... implement GS1 Standards to support the 2013 Drug ... safety and security in the pharmaceutical supply chain. ... to U.S. Pharmaceutical Supply Chain Business Processes to ... was developed in collaboration with GS1 Healthcare ...
(Date:9/17/2014)... -- Sutro Biopharma, a biopharmaceutical company developing antibody drug ... Merck KGaA, Darmstadt, Germany , which ... States and Canada , ... antibody drug conjugates (ADCs). ADCs are composed of an ... thought to specifically target and deliver the cytotoxic drug ...
(Date:9/17/2014)... ARMONK, N.Y. , Sept. 17 2014 ... Caris Life Sciences is using IBM technical computing ... profiling services for cancer patients. These services deliver ... therapeutic plans for each patient,s unique cancer, which ... costs to the healthcare system in general. ...
Breaking Medicine Technology:New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 2Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 4
... MALVERN, Pa., May 17, 2012  Egalet Ltd., a privately ... and abuse-deterrent medications, announced today Bob Radie, president and ... Life Sciences Europe conference on May 23 organized ... the company,s patented technology and pipeline of abuse-deterrent opioids ...
... LOUIS, May 17, 2012 , "9 Trends" ... , Helping Members Make Healthier Decisions , ... , Developing New Ways to Comprehensively Manage Specialty Care ... Poor health choices add billions in cost to ...
Cached Medicine Technology:Egalet to Present at Life Sciences Europe Conference 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 3Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 4Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 5
(Date:9/17/2014)... Dennis Thompson HealthDay ... -- Diabetics and dieters who turn to artificial sweeteners ... themselves any favors, a new Israeli study suggests. ... despite containing no calories, researchers found in human and ... appear to alter the bacteria residing in the intestines ...
(Date:9/17/2014)... more than 87,000 men, a global team of scientists ... common differences in the genetic code -- that increase ... believed to be the largest of its kind, has ... array of ethnic groups comprising men of European, African, ... from smaller studies, according to William B. Isaacs, Ph.D., ...
(Date:9/17/2014)... Mercy “topped out” the world’s first ... beam into place. Sister of Mercy Claudia Ward also ... and video of the event, including footage from an ... http://bit.ly/MercyVirtual .) , “The topping out means we are ... thousands of patients regardless of the hour or location,” ...
(Date:9/17/2014)... Fremont, California (PRWEB) September 17, 2014 ... remote access connectivity solutions, today announced that it ... Appliance in October 2014. This new offering will ... 365 and other Software-as-a-Service applications to enable secure ... With the rise of cloud computing, there has ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. ... companies have made good on their pledge to cut calories ... companies, acting together through the Healthy Weight Commitment Foundation, pledged ... and 2012 and 1.5 trillion by 2015. They,ve actually reduced ... met their pledge and exceeded their pledge," said lead researcher ...
Breaking Medicine News(10 mins):Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3Health News:Large study reveals new genetic variants that raise risk for prostate cancer 2Health News:Mercy Tops Out World's First Virtual Care Center 2Health News:Celestix Announces Availability of ADFS Bridge Appliance in October 2014 to Simplify the Configuration of Office 365 with Active Directory 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 3
... Kiley Carlson of Sioux City, IA will travel ... 31, 2009 to meet with congressional leaders and gain ... research toward a cure for epilepsy.Carlson, 16, is one ... in Kids Speak Up! , a national program ...
... Findings of Pilot Study at East African Health Conference ... Danya International, Inc. (Danya), a communications, research, ... pilot study on the effectiveness of mobile video-enabled phones ... tuberculosis (TB) patients during the 3rd East African Health ...
... Milwaukee MD Saves Patients Money and Improves Health ... To save you money and save your ... may need to be part medical detective as ... http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-a ) , (Photo: http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-b ...
... HOUSTON - Just more than one year after it was ... of Texas M. D. Anderson Cancer Center has introduced a ... generations of women scientists to come. , Legends and ... D. Anderson Cancer Center presents the reflections of 26 current ...
... statutory health insurances in Germany have offered an endoscopic ... all insured persons from the age of 55. Germany ... for bowel cancer a part of its statutory early ... Professor Hermann Brenner at DKFZ have now published a ...
... Scientists at the University of Liverpool have demonstrated how ... be a source of Salmonella transmission to ... living creatures that can contaminate almost any food type, ... that Salmonella which can also cause ...
Cached Medicine News:Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 3Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 4Health News:Saving Money While Protecting Your Health in Tough Economic Times 2Health News:Saving Money While Protecting Your Health in Tough Economic Times 3Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 2Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 3Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 4Health News:Germany: Colonoscopy prevents 15,000 cancer cases 2Health News:Study shows how Salmonella survives in environment 2
Curved delicate 5 mm blades....
... Micro tissue forceps "micro ... soft spring tension light-weight ... round handles, extremely light ... to handle, fatigueless working, ...
Mini blades....
Operating microscope with motorized zoom and variable focus up to 405 mm....
Medicine Products: